Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260) (Q28343932)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q63847562)
(P304) 794-7
(P407) (Q1860)
(P433) 3
(P478) 44
(P577) +2000-03-00T00:00:00Z
(P921) (Q5452194)
(Q42824440)
(P1433) (Q578004)
(P1476) "Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)" (language: en)
(P2093) L M Demeter
R W Shafer
P M Meehan
J Holden-Wiltse
W W Freimuth
M F Para
R C Reichman
(P2860) (Q28378993)
(Q27735940)
(Q28378789)
(Q28378727)
(Q28368052)
(Q28368034)
(Q28368028)
(Q28367526)
(Q28324214)
(Q28323994)
(Q29547710)
(Q33815628)
(Q33976896)
(Q41002603)
(Q37091757)
(Q37123606)
(Q42278211)
(Q55063317)
(Q43752361)
other details
description scientific article

External Links